Latest News

June 13, 2024

Dr. Jennifer Eads on nivolumab plus neoadjuvant chemoradiation in esophageal/GEJ cancer (trial EA2174)

June 13, 2024

Personalizing chemotherapy for Black women in study EAZ171 (story by the Susan G. Komen organization)

June 13, 2024

EAZ171 trial suggests Black patients with breast cancer have lower risk of taxane-induced peripheral neuropathy with docetaxel than paclitaxel

June 13, 2024

Study EAZ171 suggests docetaxel is superior for neuropathy in Black patients with breast cancer

June 13, 2024

The June 2024 News from ECOG-ACRIN blog is now available

June 3, 2024

Press Release: ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer

May 22, 2024

Press Release: TMIST breast cancer screening trial enrollment surpasses 100,000

May 16, 2024

CompassHER2 pCR trial to evaluate the HER2DX® score

May 15, 2024

Press Release: ECOG-ACRIN announces the recipients of its 2024 scientific leadership and mentorship awards


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
45

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group